ALDX

Aldeyra Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

6.5%

Short % Float

3.1d to cover · Moderate squeeze

61.6%

Inst % Float

10 holders · 2026-06-30

Knoll Capital Mana

Top Holder

9.1% of float

52.9M sh

Public Float

26/100

Dilution Score

Medium

28 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

26/100

MEDIUM

Inst: 61.65% · Top: Knoll Capital Management, LLC

Biotech Analytics

Ophthalmology

18.89

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk26

Clinical Trials25

Short Interest30